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Edited by Takashi GojoboriAbstract The physiological importance of CD98 surface anti-
gen in regulating placental trophoblast cell fusion has been
studied in a cell model of syncytialization (the cytotrophoblast
cell line BeWo following increased intracellular cAMP by
forskolin treatment) using RNA interference. CD98 protein
abundance (determined by Western blot) was decreased by 40–
50% following double-stranded small interfering RNA transfec-
tion. Cell fusion (determined by quantitative ﬂow cytometry) was
similarly inhibited and human chorionic gonadotropin secretion
was suppressed. These ﬁndings show that CD98 is involved in
the process of cell fusion necessary for syncytiotrophoblast
formation.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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During development, cytotrophoblasts fuse with each other
to generate a syncytium of trophoblasts (the syncytiotropho-
blast) covering the surface of the human placental chorionic
villi. The syncytiotrophoblast layer, in direct contact with
maternal blood, plays an important role throughout preg-
nancy since it is the site of numerous distinct placental func-
tions, including nutrient exchange and the synthesis of steroid
and peptide hormones required for normal fetal growth and
development. The molecular basis of cell fusion in this tissue
has remained ill-understood despite the recent discovery of two
human endogenous retroviral proteins (HERV-3 [1] and
HERV-W (syncytin) [2,3]) and their implication in this
process.
CD98 cell surface antigen is an integral membrane protein
[4], which is expressed on the cytotrophoblast and particularly
on the plasma membrane of the syncytiotrophoblast (func-
tionally [5], immunohistochemically [6]). This molecule has
been found to be identical to a fusion regulatory protein-1
(FRP-1) and its expression is necessary for virus-induced cell
fusion [7] and for osteoclast formation [8]. Importantly, CD98
is also able to activate speciﬁc integrins and thus may be of
particular importance in cell adhesion [9,10]. CD98 is thus a* Corresponding author. Fax: +81-82-257-5264.
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transport; the heavy chain forms part of a dimeric structure
formed with one of a family of light chains [11].
Our recent experiments showed that there is a time-depen-
dent increase in the expression of CD98 mRNA during
syncytialization of BeWo cells following forskolin treatment
[12], and further that using transient transfection with anti-
sense oligonucleotides to CD98 this molecule is involved in the
process of cell fusion necessary for syncytiotrophoblast for-
mation (syncytialization) [13]. We have now applied RNA
interference (RNAi) to reduce CD98 expression and thus as-
sess the role of this molecule in the process of syncytialization
using BeWo cells as a well-established cellular model of pla-
cental trophoblast syncytialization [14].2. Materials and methods
2.1. BeWo cell culture
Cloned BeWo cells expressing either a fusion protein of green ﬂuo-
rescent protein and human histone H2B (H2B-GFP) or a fusion pro-
tein of red ﬂuorescent protein and the mitochondrial targeting
sequence from subunit VIII of human cytochrome c oxidase (Mit-
DsRed2) were maintained at 37 C as monolayers in Ham’s F-12K
(½Ca2þ ¼ 0:92 mM) medium supplemented with 10% fetal bovine se-
rum, 2 mM L-glutamine, 100 Uml1 penicillin and 100 Uml1
streptomycin in a humidiﬁed atmosphere of 5% CO2 and 95% air [15].
These two cell lines were subcultured by treating with 0.05% trypsin in
Ca2þ- and Mg2þ-free phosphate buﬀer saline (PBS) containing 0.02%
ethylenediaminetetraacetate, mixed at 50% and seeded in 25 cm2
plastic culture ﬂasks and grown for 2–3 days to the stage of 50%
conﬂuence. At 50% conﬂuency, 30 pmol per ﬂask double-stranded
small interfering RNA (siRNA) to CD98 (Table 1) was introduced into
cells using TransIT-TKO transfection reagent according to the man-
ufacturer’s protocol by incubating cells for 12 h. Forskolin or vehicle
(dimethyl sulfoxide) was then added to the ﬁnal concentration of 100
lM, followed by further incubation for indicated times at 37 C. At the
end of the incubation period, cells were more than 95% viable as as-
sessed by trypan blue dye exclusion. Cultures were conducted in trip-
licate for each set of experiments to assess reproducibility. The
conditioned medium was collected and centrifuged at 3000· g at 4 C
for 10 min to remove cellular debris and stored at )70 C until use.
2.2. Western blot analysis
Total protein (cellular extract) was extracted from cultured cells with
PARIS according to the manufacturer’s protocol and stored at )70
C until use. The cellular extracts were mixed with Laemmli sample
buﬀer [16] and boiled for 5 min before loading. Samples (20 lg of
protein for each lane) were separated under reducing conditions on
12% (w/v) sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and transferred to nitrocellulose membrane. After blocking by incu-
bation in Tris buﬀer saline (TBS) containing 2% (w/v) bovine serumation of European Biochemical Societies.
Fig. 1. Eﬀect of double-stranded siRNA to CD98 on CD98 protein.
BeWo cells expressing either H2B-GFP or Mit-DsRed2 were mixed,
cultured and transfected without or with double-stranded siRNAs or
corresponding scrambled siRNAs. CD98 protein levels in the cellular
extracts before (control) and after a further 36 h treatment with 100
lM forskolin or with vehicle were analyzed as described in Section 2.
(A) Western blot (under reducing conditions). The results presented
are from a single representative experiment. (B) Quantiﬁcation of
CD98 protein levels. The intensity of each band was quantiﬁed by
using an image documentation and analysis system. Data represent
means S.D. of four separate experiments, expressed as percentage of
control (i.e., values without culture). *Signiﬁcantly diﬀerent from
control. ySigniﬁcantly diﬀerent from values cultured with vehicle alone.
zSigniﬁcantly diﬀerent from values cultured with forskolin alone.
siRNA1, CD98 siRNA1; siRNA2, CD98 siRNA2; Scr siRNA,
scrambled siRNA.
Table 1
Sequence of double-stranded siRNA to CD98
Sequence Position
CD98 siRNA1
Sense 50-UCUGAAGGAUGCAUCCUCA(TT)-30 1222–1240
Antisense 30-(TT)AGACUUCCUACGUAGGAGU-50
Scrambled CD98 siRNA1
Sense 50-AUCACCUUAAGACGUUCGG(TT)-30
Antisense 30-(TT)UAGUGGAAUUCUGCAAGCC-50
CD98 siRNA2
Sense 50-GAAUGGUCUGGUGAAGAUC(TT)-30 586–604
Antisense 30-(TT)CUUACCAGACCACUUCUAG-50
Scrambled CD98 siRNA2
Sense 50-GUGUAUAUGGACUGGGCAA(TT)-30
Antisense 30-(TT)CACAUAUACCUGACCCGUU-50
Two sets of double-stranded siRNA (designated CD98 siRNA1 and CD98 siRNA2) were designed to target bases (position) of the CD98 coding
sequence (Accession No. NM_002394). The control siRNAs (scrambled sequence) for each siRNA were also designed.
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overnight at 4 C in TBS containing CD98 polyclonal antibody (1:200
dilution) and 1% (w/v) BSA. The membrane was rinsed and washed
three times for 5 min in TBS containing 0.1% (v/v) Tween 20 (TBS-T),
incubated with anti-rabbit IgG peroxidase-linked antibody (1:5000
dilution) in TBS-T for 1 h at room temperature and then rinsed and
washed three times for 5 min in TBS-T followed by one wash in TBS
for 5 min. Proteins were detected with the ECL detection system. The
intensity of band for each sample was quantiﬁed using an image
documentation and analysis system.
2.3. Cell fusion analysis
The rate of cell fusion (syncytialization) was measured as described
previously by ﬂow cytometry [15]. Cells were harvested by trypsini-
zation, ﬁxed and the number of single ﬂuorescent (green or red) po-
sitive cells (i.e., non-fused or non-detectably fused cells) and double
ﬂuorescent (green and red) positive cells (i.e., detectably fused cells)
were counted using a ﬂow cytometer (BD FACSAria, Becton Dick-
inson, Franklin Lakes, NJ, USA). Twenty thousand cells were ana-
lyzed on each sample.
2.4. Human chorionic gonadotropin secretion
Human chorionic gonadotropin (hCG) secretion was determined by
measuring its concentrations in the conditioned medium by an im-
munoassay kit, which speciﬁcally detects the b-chain of hCG.
2.5. Protein estimation
Protein concentration of the cell extract was determined by the
method of Lowry et al. [17] using bovine serum albumin as a standard.
2.6. Statistical analysis
Diﬀerences between groups were analyzed using an ANOVA and
results were considered statistically signiﬁcant at P < 0:05.
2.7. Materials
BeWo cells (passage number approximately 40) were kindly pro-
vided by Dr. S.L. Greenwood (Academic Unit of Child Health, St.
Mary’s Hospital, University of Manchester). Double-stranded siR-
NA was obtained from Takara-bio (Kusatsu, Shiga, Japan) and
TransIT-TKO was purchased from Mirus (Madison, WI, USA).
PARIS was purchased from Ambion (Austin, TX, USA), CD98
(H-300) rabbit polyclonal antibody raised against a human re-
combinant protein was from Santa Cruz Biotechnology (Santa Cruz,
CA, USA) and anti-rabbit IgG, peroxidase-linked antibody and
ECL detection system were purchased from Amersham Life Science
(Amersham, Buckinghamshire, UK). Forskolin was obtained from
Sigma–Aldrich Chemical (St. Louis, Missouri, USA), tissue culture
supplements were from Gibco BRL (Rockville, MD, USA) and the
hCG enzyme immunoassay kit was from ICN Biomedicals (Irvine,
CA, USA). All chemicals were of the highest purity commercially
available.3. Results
In order to determine the eﬀect of transfection with double-
stranded siRNA to CD98 on the level of CD98 protein and
also on BeWo cell fusion, two diﬀerent sets of double-stranded
siRNA designed against diﬀerent sequences within CD98
Fig. 2. Eﬀect of double-stranded siRNA to CD98 on cell fusion. BeWo cells expressing either H2B-GFP or Mit-DsRed2 were mixed, cultured and
transfected without or with double-stranded siRNAs or corresponding scrambled siRNAs. Cells were further cultured with 100 lM forskolin or with
vehicle for 36 h. Cell fusion was analyzed on a ﬂow cytometer as described in Section 2. (A) Two parameter histogram of GFP and DsRed2
ﬂuorescence analyzed on a ﬂow cytometer. Cells in the quadrant (Q) 2 simultaneously express both H2B-GFP and Mit-DsRed2, thus fused cells.
(a) Cells before forskolin treatment (control). (b) Cells following 36 h culture without forskolin (vehicle). (c) Cells following 36 h culture with
forskolin. (d) Cells transfected with CD98 siRNA1 following 36 h culture with forskolin. (e) Cells transfected with scrambled CD98 siRNA1 fol-
lowing 36 h culture with forskolin. (f) Cells transfected with CD98 siRNA2 following 36 h culture with forskolin. (g) Cells transfected with scrambled
CD98 siRNA2 following 36 h culture with forskolin. (B) Number of fused cells. Data represent means S.D. of four separate experiments. Scr
siRNA, scrambled siRNA.
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Fig. 3. Eﬀect of double-stranded siRNA to CD98 on hCG secretion.
BeWo cells expressing either H2B-GFP or Mit-DsRed2 were mixed,
cultured and transfected without or with double-stranded siRNAs or
corresponding scrambled siRNAs. hCG concentrations in the condi-
tioned medium before (control) and after further 36 h treatment with
100 lM forskolin or with vehicle were analyzed as described in Section
2. Values are means S.D. of four separate experiments with triplicate
assay. *Signiﬁcantly diﬀerent from control. ySigniﬁcantly diﬀerent
from values cultured with vehicle alone. zSigniﬁcantly diﬀerent from
values cultured with forskolin alone. Scr siRNA, scrambled siRNA.
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were then cultured in the presence or absence of forskolin and
CD98 protein levels in the cellular extract were analyzed by
Western blotting (Fig. 1). As expected, under reducing con-
ditions a band was found at 75–80 kDa [6]. In cells not
transfected with double-stranded siRNA, forskolin addition
produced a marked (2.9-fold) increase in CD98 protein com-
pared to either pre-treatment, or to vehicle-treated cells.
Transfection with either set of double-stranded siRNA before
forskolin treatment suppressed forskolin-induced stimulation
of CD98 protein level signiﬁcantly. In contrast, scrambled
double-stranded siRNAs to CD98 showed no signiﬁcant eﬀect
on forskolin-induced stimulation of CD98 protein quantity.
Fig. 2 shows the eﬀect of transfection with double-stranded
siRNAs to CD98 on the rate of cell fusion analyzed by ﬂow
cytometry. The number of cells expressing combined green and
red ﬂuorescence (quadrant (Q) 2), that is detectably fused cells,
was clearly increased following forskolin treatment (compare
Fig. 2A,a or b with c). At 36 h in the presence of forskolin,
approximately 15% of the ﬂuorescence-positive cells were
fused (Fig. 2A,c), while in the absence of forskolin the value
was about 1% (Fig. 2A,b). In double-stranded siRNA trans-
fected cells (Fig. 2A,d, f), the number of fused cells was ap-
proximately 50–55% of that in non-transfected cells while in
cells transfected with scrambled double-stranded siRNAs
(Fig. 2A,e, g), there was no signiﬁcant eﬀect on cell fusion.
Forskolin-induced hCG secretion, a marker of syncytialization
in BeWo cells, was suppressed in cells transfected with double-
stranded siRNAs compared to untreated cells or cells trans-
fected with scrambled double-stranded siRNAs (Fig. 3).4. Discussion
The major objectives of this study were to develop and uti-
lize siRNA to directly investigate the importance of CD98 in
trophoblast cell fusion. For experimental reasons, we have
used a model human choriocarcinoma cell line which is con-sidered to have many of the properties of freshly isolated
human trophoblast [14]. That CD98 is involved in cytotro-
phoblast cell fusion is suggested by the following evidence; (1)
CD98 protein level is increased following cell fusion; (2) when
CD98 protein expression is inhibited by transfection with
double-stranded siRNAs to CD98, cell fusion and hCG se-
cretion are both suppressed; (3) scrambled double-stranded
siRNAs to CD98 have no signiﬁcant eﬀect on forskolin-in-
duced stimulation of cell fusion and hCG secretion. In contrast
to our earlier work with anti-sense oligonucleotides, the siR-
NA experiments reported here give important mechanistic in-
sight into how CD98 function may be controlled biologically.
Thus, the functional experiments (Figs. 2 and 3) show that the
stability of the mRNA encoding CD98 must directly alter the
level of surface expression of this protein, since recent work
shows that it is the recruitment of activated CD98 to the cell
membrane that is integral to the normal process of syncytial-
ization (data not shown). Additionally, since in the absence of
forskolin stimulation the slow rate of spontaneous BeWo cell
fusion was unaltered by siRNA to CD98 (data not shown), we
can conclude from these new experiments using the siRNA
technique that the steady state level of CD98 mRNA must be
suﬃcient to regulate fusion under stimulated but not under
resting conditions when other factors (such as CD98 traﬃck-
ing to the cell surface) must be rate limiting. Using immuno-
histochemistry, we have previously shown that CD98
immunoreactivity is prominent particularly at the basal surface
(in direct contact with the underlying cytotrophoblast) of the
syncytiotrophoblast of the human placenta [13]. The fact that
CD98 immunoreactivity is detected in human chorionic villous
trophoblast in situ as well as in a choriocarcinoma cell line
(BeWo) in vitro (Fig. 1) suggests that the functional results in
the BeWo model system described here will have relevance
to understanding syncytialization in normal placental
development.
Syncytialization is an unusual biological process that occurs
in only a few human lineages (e.g., in the development of
myotubes, osteoclasts, syncytiotrophoblasts), and its mecha-
nism remains to be elucidated. In addition to CD98, two
molecules are currently considered to play an important role in
syncytialization. HERV-3 is an endogenous retroviral gene
product expressed in syncytiotrophoblasts and circumstantial
evidence suggests that it may play a role in cytotrophoblast
diﬀerentiation [1]; however, it is probably not essential since 1%
of the Caucasian population lack any functional protein [18].
Syncytin, a protein encoded by an envelope gene of the recently
identiﬁed human endogenous retrovirus-W (HERV-W) [19],
may mediate placental cytotrophoblast fusion in vivo, and thus
be important in human placental morphogenesis [2,20,21]. In
primary culture of isolated cytotrophoblast cells, the transcript
levels of syncytin increase with the diﬀerentiation and fusion of
cytotrophoblasts into syncytiotrophoblasts [22]. Immunohis-
tochemical analysis showed syncytin (HERV-W) expression
restricted to placenta [3], however, there is little consensus re-
garding its localization in villous trophoblast [20,23]. Syncytin
is mis-expressed in pre-eclampsia where syncytiotrophoblast
formation is defective and syncytin is anomalously distributed
on the apical surface of syncytiotrophoblast [24]. The viral
homolog, ERV-W, is also a highly fusogenic membrane gly-
coprotein that can induce syncytium formation upon interac-
tion with the type D mammalian retrovirus receptor [3] – an
amino acid transporter B0 (ASCT2) [25,26]. The relative
Y. Kudo, C.A.R. Boyd / FEBS Letters 577 (2004) 473–477 477abundance of the mRNAs of syncytin and its receptor – amino
acid transport system B0 – changes reciprocally in BeWo cells
during forskolin-induced syncytialization [27].
Our current studies are directed to developing and utilizing
siRNAs to these possible molecules for further analysis of the
molecular basis of trophoblast syncytialization.
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